Hudson Bay Capital Management’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.6M Buy
+1,747,598
New +$19.6M 0.07% 141
2023
Q3
Sell
-22,500
Closed -$422K 870
2023
Q2
$422K Sell
22,500
-6,500
-22% -$122K ﹤0.01% 562
2023
Q1
$418K Buy
+29,000
New +$418K ﹤0.01% 587